---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-011379"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2023-04-27T23:59:59+00:00"
generated_at: "2026-06-16T09:12:27.191640+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Reviva grants stock options to CEO, CFO, and VP; 1.303M shares total

## Summary
- CEO Dr. Bhat granted option for 443,000 shares; CFO Prabhu for 170,000 shares.
- VP Seema Bhat (CEO's spouse) granted option for 150,000 shares.
- Options vest 50% immediately, then 1.389% monthly; exercise price $6.74.
- Additional 540,000 options awarded to other employees under 2020 Plan.

## SEC filing metadata
- accession: 0001437749-23-011379
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2023-04-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774923011379/0001437749-23-011379-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774923011379/rvph20230426_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-011379
- JSON: https://secwatch.observer/filing/0001437749-23-011379.json
- Plain text: https://secwatch.observer/filing/0001437749-23-011379.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.